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Correcting for Sample Contamination
in Genotype Calling of DNA Sequence Data
Matthew Flickinger,1 Goo Jun,1,2 Gonc¸alo R. Abecasis,1 Michael Boehnke,1,* and Hyun Min Kang1,*
DNA sample contamination is a frequent problem in DNA sequencing studies and can result in genotyping errors and reduced power for
association testing. We recently described methods to identify within-species DNA sample contamination based on sequencing read
data, showed that our methods can reliably detect and estimate contamination levels as low as 1%, and suggested strategies to identify
and remove contaminated samples from sequencing studies. Here we proposemethods tomodel contamination during genotype calling
as an alternative to removal of contaminated samples from further analyses. We compare our contamination-adjusted calls to calls that
ignore contamination and to calls based on uncontaminated data. We demonstrate that, for moderate contamination levels (5%–20%),
contamination-adjusted calls eliminate 48%–77% of the genotyping errors. For lower levels of contamination, our contamination
correction methods produce genotypes nearly as accurate as those based on uncontaminated data. Our contamination correction
methods are useful generally, but are particularly helpful for sample contamination levels from 2% to 20%.Introduction
Advances in next-generation sequencing have resulted in
higher sequencing throughput and lower sequencing
costs, enabling a wide range of large-scale genomic studies.
Although the quality of sequence data is generally improv-
ing, methods and protocols are imperfect and errors inev-
itably occur. One such error is DNA sample contamination,
in which DNA from two ormore individuals is accidentally
mixed.
DNA sample contamination is a common occurrence in
large-scale sequencing studies and can arise at many steps
of the experiment: during sample collection; any time
a sample is placed into or taken out of storage; during ship-
ping, particularly if plates are not properly sealed or kept
frozen; and during the many steps of preparing DNA
sequencing libraries. For example, if barcoded samples
are amplified in pools, template switching might occur if
amplification conditions result in templates that are only
partially extended at the end of each round, resulting in
DNA from one sample being paired with the barcode of
another. Even if samples are sequenced without contami-
nation on a particular run, a sample might be included
in multiple runs and merged afterward. If samples are
improperly labeled or there are errors in the processing
pipeline, reads from multiple samples might be combined
in error.
Screening for sample contamination is becoming a
standard quality-control step for DNA sequencing pro-
jects, and the patterns of contamination identified vary
greatly. In the 1000 Genomes Project, DNA samples
were screened for contamination1 by our method.2 Out
of 1,166 sequenced samples, 39 had an estimated contam-
ination level >3% and were dropped from analysis. In a1Department of Biostatistics and Center for Statistical Genetics, University of
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each with estimated contamination >25%. These samples
were traced back to two 96-well plates in which contami-
nation probably occurred during shipping. In a type 2
diabetes exome sequencing study (unpublished data),
~20% of a set of DNA samples had estimated contamina-
tion rates from 10%–15%. Here, the apparent cause was a
change in the library preparation protocol to allow pro-
cessing of two samples at a time. Even in the most chal-
lenging contamination scenarios we have encountered,
a subset of DNA samples show no evidence of contamina-
tion, so that most studies include a mixture of contami-
nated and uncontaminated DNA samples.
If left uncorrected, contamination results in systematic
genotype misclassification with a bias in favor of hetero-
zygotes. This bias arises because when a mixture of two
DNA samples is sequenced, the presence of the contami-
nating sample DNA makes it more likely that reads sup-
porting different alleles at the same site will be present.
The impact of contamination typically increases with
the contamination level and decreases with sequencing
depth.
Here we propose likelihood-basedmethods that improve
genotyping accuracy by explicitly modeling DNA sample
contamination during genotype calling. We apply these
methods to in silico contaminated samples based on
low-pass and high-depth sequence data from the 1000
Genomes Project and to actual contaminated samples
from a type 2 diabetes exome sequencing project. We
demonstrate that over a wide range of contamination
levels and sequencing depths, modeling contamina-
tion can dramatically increase concordance between ge-
notype calls and the true underlying genotypes, resulting
in larger effective sample sizes for downstream geneticMichigan, School of Public Health, 1415 Washington Heights, Ann Arbor,
ity of Texas Health Science Center at Houston, 7000 Fannin Street, Houston,
y of Human Genetics. All rights reserved.
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Table 1. Conditional Probability Pðbij
gi; eijÞ of Base bij Given
Genotype gi and Error Event eij
True
Genotype
Base Read Error
Indicator P(bij ¼ A) P(bij ¼ B) P(bij ¼ E)
gi ¼ AA eij ¼ 0 1 0 0
eij ¼ 1 0 1/3 2/3
gi ¼ AB eij ¼ 0 1/2 1/2 0
eij ¼ 1 1/6 1/6 2/3
gi ¼ BB eij ¼ 0 0 1 0
eij ¼ 1 1/3 0 2/3
Assumes a biallellic site with alleles A and B; E represents any base other than A
or B. eij ¼ 1 corresponds to a sequencing error; or 0 corresponds to a correct
base call.association studies than is possible by either ignoring
contamination or dropping contaminated samples from
the analysis.Material and Methods
Outline
First, we introduce notation and assumptions and review our
methods to detect DNA sample contamination.2 Second, we
describe our model for calling genotypes from sequence read
data and propose a generalization of that model to account for
DNA sample contamination. Third, we extend our model and
method to provide even better results when the source of contam-
ination is known and the corresponding sample is also sequenced.
Finally, we describe a series of experiments and datasets used to
evaluate the performance of our proposed methods.
Detecting and Estimating DNA Sample
Contamination
Consider the case where one DNA sample is contaminated by
another.2 Let g
ð1Þ
i and g
ð2Þ
i be the genotypes for the intended and
contaminating samples, respectively, at variant site i (1% i% M).
Let bij be the observed base at position i for read j (1% j% Ri) and eij
be a latent variable indicating whether a base calling error
occurred (eij¼ 1) or did not (eij¼ 0). Finally, let a be the proportion
of reads from the contaminating sample and p be the proportion
of samples that are contaminated. We assume that sites are
independent, that reads at each site are independent, and that
sequencing errors are equally likely to result in any of the three
incorrect bases.
To model the probability of observing a particular base, we
employ the mixture model
P

bij j gð1Þi ; gð2Þi ;a

¼ ð1 aÞP

bij j gð1Þi

þ aP

bij j gð2Þi

(Equation 1)
where
P

bij j gi
 ¼ Pbij j gi; eij ¼ 1 Peij ¼ 1þ Pbij j gi; eij ¼ 0 Peij ¼ 0:
We present the read probabilities allowing for error Pðbij
gi; eijÞ
in Table 1. We estimate the probability of a read error as
Pðeij ¼ 1Þ ¼ 10Qij=10 and P(eij ¼ 0) ¼ 1  P(eij ¼ 1), where Qij
is the phred-scaled base quality score for the sequence data.3The AmerTo estimate the genotype probability P(gi), we use allele fre-
quencies from the population from which the sample was drawn
and assume Hardy-Weinberg equilibrium. Allele frequencies can
be estimated from a closely related reference population (for
example, HapMap or 1000 Genomes), from array-based genotypes
from the same population, or even from the proportion of reads
that carry each allele across all sequenced samples.
Taking expectations over the unknown genotypes and assuming
that all reads and loci are independent, we write the likelihood for
contamination level a in a sample as
LðaÞ ¼ PðB jaÞ ¼
YM
i¼1
X
g
ð1Þ
i
X
g
ð2Þ
i
(
P

gð1Þi

P

gð2Þi
YRi
j¼1
h
ð1 aÞ
3P

bij j gð1Þi

þ aP

bij j gð2Þi
i)
:
For each sample, we first maximize L(a) by using a grid search in
the interval 0.0 % a % 0.5 and then apply Brent’s4 algorithm to
obtain themaximum likelihood estimate of a. By using information
across a large number of variants M, we determine whether the
observed reads are better explained by a single sample or a combina-
tionof twosampleswithmixingproportiona. Even ifnotallmarkers
are independent, there is little impact on the estimation of a.
Genotype Likelihoods for Contaminated Sequence
Data: Source Unknown
Having estimated the contamination level a for sample k, we
explicitly model contamination during genotype calling by using
the estimated sample-specific contamination rate bak. Treating the
genotypes of the intended and contaminating genotypes as the
unknowns, we calculate the likelihood for the combination of
genotypes via the probability defined in Equation 1 as
L

gð1Þi ; g
ð2Þ
i jBi; bak ¼ PBi j gð1Þi ; gð2Þi ; bak
¼
YRi
j¼1
h
ð1 bakÞPbij j gð1Þi þ bakPbij j gð2Þi i;
where Bi ¼ fbij
 j ¼ 1. Rig is the set of bases overlapping position
i in the sequence reads that cover the variant site. Usually,
we do not know the genotype of the contaminating sample, and
so we sum over this unknown variable to obtain the genotype
likelihood
L

gð1Þi jBi; bak ¼ PBi j gð1Þi ; bak ¼X
g
ð2Þ
i
h
P

gð2Þi

P

Bi j gð1Þi ; gð2Þi ; baki:
In contrast to the analysis in which we identified contaminated
samples and estimated contamination level (a) for each sample k
by using a list of known variant sites and allele frequencies, during
genotype calling we examine every site. This step requires allele
frequencies at each site, which we estimate via the EM algo-
rithm5 to maximize the above likelihood. Thus, we estimate the
allele frequency as:
bf i ¼ arg maxfi Yn
k¼1
X
gik
P

gik j fi

PðBik j gik; bakÞ;
where gik is the true genotype for individual k (1% k% n) at site i.
Given the allele frequency estimate bf i, we estimate the genotype
probabilities assuming Hardy-Weinberg equilibrium.
Finally, to call a genotype for an individual at locus i, we select
the value of g
ð1Þ
i with the highest likelihood. We calculate theican Journal of Human Genetics 97, 284–290, August 6, 2015 285
corresponding genotype dosage (Di ranging from 0 to 2) for bi-
allelic sites by taking a weighted average of the number of alterna-
tive alleles for each of the possible genotypes g
ð1Þ
iDi ¼
P

g
ð1Þ
i ¼ AR j Bi; ba; bf iþ 2,Pgð1Þi ¼ AA j Bi; ba; bf i
P

g
ð1Þ
i ¼ RR j Bi; ba; bf iþ Pgð1Þi ¼ AR j Bi; ba; bf iþ Pgð1Þi ¼ AA jBi; ba; bf i ; (Equation 2)where R and A are the reference and alternate alleles and
P

g
ð1Þ
i j Bi; ba; bf ifPBi j gð1Þi ; ba Pgð1Þi ; bf i:
Genotype Likelihoods for Contaminated Sequence
Data: Source Known
If the identity of the contaminating sample is known, as in the
type 2 diabetes example described in the Introduction, we can
use that information to improve genotype calls. In that case, we
examine all available data from the paired DNA samples and call
their genotypes simultaneously by considering all potential 3 3
3 ¼ 9 genotype pairs ðgð1Þi ; gð2Þi Þ. Let Bð1Þi ¼ fbð1Þij
 j ¼ 1. Rð1Þi g and
B
ð2Þ
i ¼ fbð2Þij
 j ¼ 1. Rð2Þi g be the observed bases for reads labeled
as originating from samples 1 and 2, respectively, and let bað1Þ
and bað2Þ be the estimated contamination levels for those two sam-
ples. We then write the joint likelihood for the paired samples as
L

gð1Þi ; g
ð2Þ
i jBð1Þi Bð2Þi ; bað1Þ; bað2Þ ¼YR
ð1Þ
i
j¼1
h
1 bað1ÞPbð1Þij j gð1Þi þ bað1Þ
3P

b
ð1Þ
ij j gð2Þi
i
3
YRð2Þi
j¼1
hbað2ÞPbð2Þij j gð1Þi 
þ 1 bað2ÞPbð2Þij j gð2Þi i:
This likelihood can also be calculated for different possible con-
taminating samples and compared to find the most likely source
of contamination (assuming both samples were sequenced).
When inconvenient to work with the joint likelihood (such as
when calculating per-individual dosages), we calculate per-sample
genotype likelihoods by marginalizing over the partner genotype.
L

g
ð1Þ
i jBð1Þi Bð2Þi ; bað1Þ; bað2Þ¼X
g
ð2Þ
i
h
P

g
ð2Þ
i

P

B
ð1Þ
i B
ð2Þ
i j gð1Þi ; gð2Þi ; bað1Þ; bað2Þi:
We also calculate these individual likelihoods prior to genotype
refinement for low-pass sequence data (see below).
LD Refinement for Low-Pass Sequence Data
Genotype refinement using linkage disequilibrium (LD) on low-
pass sequence data leverages information about surrounding
markers to help infer haplotypes and improve genotype accu-
racy.6,7 After adjustment for contamination, we use Beagle6 on
our genotype likelihoods for low-pass (43–63) whole genome
data to refine and improve genotype calls. Such an adjustment is
less important for exome sequence data because of insufficient
flanking markers to infer haplotypes accurately.
Experimental Data
To construct in silico contaminated samples to test our methods,
we chose 198 European 1000 Genomes Phase 1 samples1 with (1)286 The American Journal of Human Genetics 97, 284–290, August 6low-pass (43–63) genome sequence data, (2) high-depth (503–
1503) whole exome sequence data, (3) Illumina HumanOmni2.5
and HumanExome chip data, and (4) estimated contaminationlevels ba < 0.5% for chip and sequence data. We chose two samples
at a time (without replacement) and combined sequence reads to
achieve synthetic contamination levels (a) from 2% to 30%. We
paired samples with similar depths so as to approximately preserve
total read counts and varied the proportion of contaminated sam-
ples (p) in each simulation from 0% to 100%.
We also analyzed 1,503 samples from a type 2 diabetes exome
sequencing project (average sequencing depth ~1003), 1,009 of
which (67%) were estimated to have contamination level ba >
5%. In this study, we learned after sequencing was completed
that changes to sequencing library preparation protocols that
were designed to improve efficiency and reduce cost resulted in
contamination due to template switching during PCR amplifica-
tion of pairs of barcoded samples. In this case, we could reconstruct
the identity of the contaminating sample by checking experi-
mental records to identify samples that were amplified together.Evaluation
For both examples, we compared sequence-based best-guess geno-
types and genotype dosages to available array-based genotypes
to estimate genotype concordance and squared Pearson’s correla-
tion r2 between true genotypes and estimated genotype dosages.
The genotypes for the in silico contaminated low-pass samples
were LD refined and then compared to all 41,847 Illumina
HumanOmni2.5 genotype array chromosome 20 SNPs. Genotypes
for in silico contaminated high-depth samples were compared to
all 33,884 SNPs from the Illumina HumanExome array that were
variable within the 198 samples from the 1000 Genomes Project.
Genotypes for the type 2 diabetes example were compared to all
3,881 SNPs from the Affymetrix 6.0 array that overlapped
the targeted sequence regions and were variable within the
sequenced samples.Results
In Silico Contaminated Data: Contaminating Sample
Unknown
When we did not model contamination, increasing DNA
contamination levels (a) resulted in decreasing concor-
dance between sequence and array genotypes. For low-
pass whole genome sequence data, as a increased from
2% to 30%, total genotype concordance decreased from
98.1% to 83.8%, compared to an average concordance of
98.9% for uncontaminated samples (Figure 1A; Table S1).
For high-depth exome sequence data, total concordance
decreased from 99.6% to 92.9% over the same contamina-
tion range compared to 99.8% for uncontaminated sam-
ples (Figure 1B; Table S1). Similarly, r2 values for genotype
dosages decreased from>0.96 to<0.75 as a increased from, 2015
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Figure 1. Effects of Contamination
Adjustment on Constructed Contami-
nated DNA Samples: Genotype Concor-
dance and r2
Each point represents overall genotype
concordance or dosage r2 for contaminated
samples when the proportion of contami-
nated samples (p) is 50%. Genotype
concordance (A and B) and dosage (r2) (C
and D) for low-pass data (A and C) and
high-depth exome data (B andD) is shown.2% to 30% (Figures 1C and 1D). Genotyping errors resulted
in an increase in heterozygous calls roughly equal to a for
the high-depth data and a/2 for the low-pass data
(Figure S1). The impact of contamination was greater for
common variants than for rare ones (Table S1), corre-
sponding to the greater probability of a contamination re-
sulting in a false heterozygote.
Applying our method to these contaminated samples
markedly increased genotype concordance and genotype
dosage (r2). Estimated sample contamination levels ðbakÞ
closely matched intended a values (Table S2). By accurately
modeling contamination, we reduced the difference in ge-
notype concordance rates between the contaminated and
uncontaminated samples by up to 60%–80% for the high-
depth exomes and up to 50%–80% for the LD-refined
low-pass genomes (Figures 1A and 1B) for contamination
levels 5%–20%.Weobserved a similar pattern for r2 (Figures
1C and 1D). For the low-pass data, these improvements
were seen only after LD refinement (Figure S2).
Joint calling uncontaminated samples with contami-
nated samples had little effect on the genotypes for the
uncontaminated samples. For low-pass data, when the
proportion of contaminated samples (p) was 50% and
contamination levels (a) were%30%, the largest observed
reduction in genotype concordance for uncontaminated
samples was 0.4%; average reductions were ~0.2%. Results
changed only slightly as we varied the proportion of
contaminated samples (p) from 5% to 90% (Figure 2). For
high-depth data, the effect using our contamination-awareThe American Journal of Human Glikelihoods when calling genotypes
for uncontaminated samples was
negligible for all p and a (Table S3).
In Silico Contaminated Data:
Contaminating Sample Known
When the source of the contami-
nating DNA sample was known and
sequence data for both samples
were available, modeling this infor-
mation explicitly further improved
concordance with array genotypes.
For low-pass data, adding the pair
information reduced the difference
in concordance by an additional
~25% as a increased from 2% to20% (Figure 1A). However, at a ¼ 30%, concordance
was actually slightly lower. This reduction in concor-
dance appears only after LD adjustment on the data; it
might be the result of a loss of information from margin-
alizing our pairwise genotype likelihoods as required for
analysis with Beagle. Improvements to r2 ranged from
0.1% to 1.3% for a ¼ 2% to 20%. For high-depth data,
we did not see a meaningful difference in concordance
or r2 when using the known pair information (Figure 1B).
In Silico Contaminated Data: Association Information
Ultimately we wish to use the sequence-based genotypes
to test for disease or trait association. In association anal-
ysis, we can choose one of three strategies: (1) ignore
contamination, (2) exclude highly contaminated samples
from analysis, or (3) adjust for contamination. To esti-
mate the relative efficiencies of these three strategies,
we note that effective sample size scales linearly with
nr2, the product of sample size and the squared correla-
tion between the true genotype and the sequence-based
genotype dosages.8 Because even contaminated samples
provide information about the true underlying genotype
(r2 > 0), including contaminated samples could provide
association information even when contamination is
ignored. The reduction in sample size due to contamina-
tion is at least 80% smaller when applying our correc-
tion compared to dropping contaminated samples (Table
2). In our evaluations, we maximized effective sample
size when adjusting for contamination and using allenetics 97, 284–290, August 6, 2015 287
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Figure 2. Effects of Increasing Propor-
tion of Contaminated Samples on Geno-
type Concordance for Various Levels of
Contamination
Notation: p, proportion of contaminated
samples; a, level of contamination. Geno-
type concordance of contaminated (A and
B) and uncontaminated (C and D) samples
for low-pass data (A and C) and high-depth
exome data (B and D) is shown.
Table 2. Effective Sample Size for Association Test
Method
Percent of Samples Contaminated
5% 10% 25% 50% 75% 90% 100%
Low-Pass
Adjusted 194 194 193 192 191 190 190
Ignored 193 193 190 186 182 179 177
Dropped 184 174 144 96 47 18 0
High-Depth
Adjusted 195 195 195 194 194 193 193
Ignored 195 194 192 189 186 184 182
Dropped 186 176 146 98 48 18 0
Shown here are the effective sample size estimates when a ¼ 10% and total
sample size is 198 under three scenarios: all samples included and adjusted
with our method (‘‘adjusted’’), all samples included but contamination ignored
(‘‘ignored’’), and contaminated samples ðba > 0:01Þ removed from analysis
(‘‘dropped’’).samples, whether contaminated or not. For example,
when all samples are contaminated at a ¼ 10%, associa-
tion information for the low-pass data is reduced by
10.6% if we ignore contamination and 4.0% if we cor-
rect for contamination (compared to 8.0% and 2.5%,
respectively, for high-depth data). In this example, where
all samples are contaminated, it would have been
impractical to exclude contaminated samples from asso-
ciation analyses.
In Silico Contaminated Data: Impact of Over- or
Underestimating Contamination
To evaluate whether misspecified values of a could result
in decreased genotype quality, we ran simulations in
which we scaled the contamination estimate ba by 0.5,
0.75, 1.5, and 2 for samples in which the true a ¼ 5%,
10%, or 15%. Overestimating ba had little impact on
total concordance and r2 whereas underestimating
contamination more negatively affected both statistics
(Figure S3). For the low-depth data, overestimating ba
by 1.53 actually resulted in better concordance then
using the ‘‘true’’ ba; this effect was observed only after
LD refinement. The difference in concordance when
reducing a by half was at least 40% greater than differ-
ence from doubling a for the low-pass samples; there
was very little difference for the high-depth samples.
The negative impact of inflated ba estimates for samples
that were not contaminated was very modest compared288 The American Journal of Human Genetics 97, 284–290, August 6, 2015to the benefits of modeling contami-
nation for the remaining samples.
Type 2 Diabetes Data
Convinced of the value of adjusting
for contamination, we next applied
our method to data from the type 2
diabetes exome sequencing project.
In these data, bp ¼ 67% of samples
were contaminated and we knew the
likely contaminating sample. When
we applied our correction methods,
concordance with array genotypes
dramatically improved: the average
per-sample concordance increased
from 94.5% to 99.4% (a 9-fold reduc-
tion in discordance), further increas-
ing to 99.6% (a 14-fold reduction indiscordance) when we both modeled contamination and
used knowledge of its source. Similar patterns were
observed for non-reference concordance and r2 (Table 3).
Discussion
We have shown that genotyping accuracy for contami-
nated samples can be dramatically improved by modeling
Table 3. GWAS Concordance for Type 2 Diabetes Exome
Sequencing Databa No. Samples Ignored Adjusted Paired
Total Concordance
0%–1% 202 0.998 0.998 0.998
1%–5% 293 0.996 0.998 0.998
5%–10% 218 0.958 0.997 0.998
10%–15% 591 0.920 0.993 0.996
15%–20% 169 0.878 0.984 0.992
>20% 30 0.841 0.950 0.971
Total 1,503 0.945 0.993 0.996
Non-reference Concordance
0%–1% 202 0.996 0.997 0.997
1%–5% 293 0.992 0.995 0.995
5%–10% 218 0.908 0.993 0.994
10%–15% 591 0.833 0.985 0.991
15%–20% 169 0.760 0.964 0.983
>20% 30 0.702 0.890 0.936
Total 1,503 0.882 0.985 0.991
r2
0%–1% 202 0.997 0.998 0.998
1%–5% 293 0.994 0.996 0.996
5%–10% 218 0.929 0.995 0.996
10%–15% 591 0.863 0.990 0.994
15%–20% 169 0.791 0.977 0.989
>20% 30 0.725 0.930 0.946
Total 1,503 0.905 0.990 0.994
Mean per-sample genotype accuracy with the GWAS data when we ignore
contamination, adjust without regard for the source of contamination, and
adjust using known contamination source.contamination using a mixture model. For example, in the
type 2 diabetes exome sequencing example, our method
reduced genotype discordance by 14-fold (4.2% to 0.3%)
for a ¼ 5%–10% contaminated samples. Consistent with
our previous study, we observed that even low levels of
contamination (e.g., a ¼ 2%–5%) can result in increases
in genotype discordance of >2-fold. Our correction
method nearly eliminates the impact of low levels of
DNA contamination (a ¼ 2%–5%) and reduces by >80%
genotype discordance incurred by moderate level of DNA
contamination (a¼ 5%–15%) in the type 2 diabetes exome
sequencing examples. We expect our method to be partic-
ularly useful when a large fraction of sequenced samples
are contaminated at small to moderate levels (a ¼ 2%–
15%).
We demonstrated (Figure S3) that genotype calling
methods that model contamination perform best when
the contamination level a is well estimated and that under-The Amerestimating a is more detrimental than overestimating
it. Situations that can lead to deflated contamination
estimates are (1) the use of misspecified allele frequency
estimates (incorrect population as well as systematic
overestimates or underestimates; data not shown), (2)
contamination from related individuals,2 and (3) limited
sequencing library complexity, which results in decreased
heterozygosity. If one or more of these situations are
suspected, modestly inflating (e.g., 2%–5%) the estimated
contamination level ba when correcting for contamination
can improve overall genotype accuracy.
As long as contamination affects case and control sam-
ples similarly, we do not expect contamination adjust-
ments to increase the rate of false positive findings in
downstream association studies. For single-variant asso-
ciations, results depend on accurate estimations of allele
frequency differences in case and control subjects. As
long as contamination patterns do not differ drastically
in the case and control subjects and there are no issues of
population stratification, we can accurately estimate allele
frequencies after correction (Figure S4). For rare-variant as-
sociation, contaminated samples can appear to carry high
numbers of rare heterozygous variants when analyzed with
standard protocols. Our proposed correction will decrease
the number of false positive heterozygotes (Figure S5), so
false positive associations will be less likely.
Althoughwe have focused on sequencing genomic DNA,
in principle our methods can be used for other sequencing
studies as well. For example, we have used our methods to
identify contamination in RNA-seq experiments. Using
our existing method and restricting analyses to expressed
exons in protein-coding genes, we detected that 11 of 249
RNA-seq samples were contaminated by >2%. Detection
and estimation of contamination in these experiments
might bemademore robust by accounting for allele-specific
expression (ASE), where gene transcription varies based on
allele; we are exploring this possibility.
We described the methods in this paper specifically in
the context of biallelic SNPs. Extension to multiallelic
SNPs is straightforward, requiring only that we sum over
a larger number of possible genotypes. Genotyping of
other variant types, such as indels and structural variants,
is also affected by contamination. We expect that the same
principles, focused on modeling the observed data as a
mixture of two samples, can be usefully applied to these
more complex situations.
We observed that the LD-aware genotype refinement
algorithm improves genotype accuracy for low-pass
sequence data. However, accuracy was still substantially
lower than for uncontaminated data when the contamina-
tion level a was high. This might be due in part to the fact
that our LD-aware genotype refinement algorithm is not
aware of the possibility of contamination. With increasing
interest in whole genome sequencing studies, accounting
for the contamination in the genotype refinement step
has the potential to further improve genotyping and
phasing accuracy.ican Journal of Human Genetics 97, 284–290, August 6, 2015 289
Our contaminationmodelingmethods are implemented
in the program cleanCall (source code is available online).
cleanCall requires sequencing data in samtools8 pileup
format. Extracting pileups only for variant sites allows
cleanCall to read data quickly compared to scanning large
BAM files. The total runtime for cleanCall is comparable to
other simple likelihood-based genotype callers; modest
additional time is spent estimating allele frequencies via
the EM algorithm, but the average number of iterations
at a given site is minimal (2–5) and does not significantly
affect overall performance.
We developed methods to correct for DNA contamina-
tion in variant calling by extending our likelihood-based
framework to detect and estimate contamination. Our
correction methods improve genotype calling accuracy
and association power compared to ignoring contamina-
tion or discarding contaminated samples. Even if the
contamination level is low (ba < 5%), we observe consider-
able improvement in genotype accuracy with our correc-
tion methods. Our methods are effective both for high-
depth and low-pass data, and given the ubiquity of DNA
sample contamination, we expect our methods to be of
real benefit to a large number of DNA sequencing studies.
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